CPT code 21925: Deep soft tissue biopsy of the back or flank

Key takeaways

CPT code 21925 covers a deep biopsy of soft tissue in the back or flank. It is a biopsy, so the lesion stays in the patient.

Medicare assigns 21925 a 090 global period, which treats a diagnostic biopsy as major surgery with 90 days of included follow-up.

The 2026 national payment is about $543 in a practice and about $373 in a facility, from total RVUs of 16.26 and 11.16.

Work RVU is 4.51, and depth wording is the only thing separating 21925 from 21920. A downcode to 21920 costs roughly $279.

Practice management software like Pabau ties the depth wording in the procedure note to the code on the claim, so fewer claims come back.

CPT code 21925 is a deep biopsy of soft tissue in the back or flank. It sits in the Musculoskeletal System chapter of the CPT code set, which the American Medical Association (AMA) maintains. A specimen goes to pathology, and the mass itself stays in the patient.

One detail trips billers up. Medicare treats 21925 as major surgery with a 090 global period, even though nothing is removed. That means 90 days of bundled postoperative care on a diagnostic procedure. It also changes which E/M modifier belongs on the visit that led to the biopsy.

Orthopedic surgeons, general surgeons, and oncologists are the primary users of this code. It comes up when a palpable mass in the back or flank needs histology before a treatment plan can be set. Dermatology billing teams also see it where soft tissue tumors of uncertain behavior are under evaluation.

Procedure description: What CPT 21925 covers

CPT 21925 covers an open incision through skin and subcutaneous fat to reach deeper soft tissue, where a specimen is taken. Depth is what separates this code from its superficial counterpart, 21920. It also drives the clinical complexity and the payment attached to the code.

This is not an excision code. If the surgeon removes the whole lesion, the correct code sits in the 21930 to 21936 range instead. That choice turns on depth, size, and whether the resection was radical. Reporting an excision code for a biopsy is upcoding.

• Incision and dissection: The surgeon opens the skin and separates subcutaneous tissue to reach the deeper fascial or muscular plane.
• Tissue sampling: A specimen is taken from the deeper layer, typically muscle, fascia, or an identifiable mass below the subcutaneous fat.
• Lesion left in place: Only a sample is removed. The mass remains in situ pending the pathology result and any later treatment decision.
• Anatomical region: Restricted to the back or flank. Adjacent regions such as the extremities and abdomen have separate code sets.
• Closure: The wound is closed in layers. Local or general anesthesia is used depending on depth and patient factors.
• Specimen handling: The specimen goes for pathological analysis, and documentation must link the biopsy to the resulting pathology report.

Plastic surgery practices and musculoskeletal teams use it when imaging suggests a deep-seated lesion that needs a histological diagnosis first. It does not cover needle biopsies. Percutaneous needle sampling of muscle is CPT 20206.

CPT 21920 vs CPT 21925: Superficial vs deep biopsy

The depth of tissue accessed is the only differentiator between these two codes, and it is worth about $279 a claim. Payers downcode to 21920 when the operative note does not confirm dissection below the subcutaneous layer. The two codes also carry different global periods.

The global period difference matters as much as the money. Choosing 21925 commits your practice to a 90-day postoperative window instead of a 10-day one. So treat the depth qualifier in the operative note as mandatory, not as a nice-to-have.

RVU values and the 2026 conversion factor

The figures below come from the CMS RVU26A file, the relative value file for the 2026 physician fee schedule. It applies to services furnished from January 1, 2026. CMS resets RVUs every year, so confirm current values in the CMS relative value files before you calculate expected payment.

Multiply total RVUs by the 2026 conversion factor of $33.4009 to reach the national amount before geographic adjustment. That works out at roughly $543 in a practice and $373 in a facility. Each annual fee schedule resets these numbers, so rerun the math every January.

Medicare reimbursement by place of service

Payment for CPT 21925 depends on place of service. The non-facility rate is higher because the practice absorbs overhead that a hospital or surgery center would otherwise carry. Use the CMS Physician Fee Schedule lookup tool to confirm the amount for your locality, since geographic adjustments apply.

The spread between the two rates is about $170 per case, which is why place of service is worth auditing. Both figures are national averages drawn from the 2026 fee schedule and will shift with your locality. Private payer rates are negotiated per contract and move independently of Medicare.

The 090 global period and postoperative billing

CPT 21925 carries a 090 global period, which makes it a major surgical procedure under Medicare. Payment covers the day before the procedure, the biopsy itself, and 90 days of routine follow-up. Superficial biopsy code 21920 sits at 010 instead, so the two codes are governed by different rules.

• What the payment includes: The preoperative visit the day before, the biopsy, wound checks, suture removal, and routine follow-up through day 90.
• Decision for surgery: An E/M visit on the day of or the day before takes modifier 57. Modifier 25 belongs to minor procedures with a 000 or 010 global period, so it is the wrong choice here.
• Unrelated care in the window: Use modifier 24 on an unrelated E/M visit and modifier 79 on an unrelated procedure. The documentation must show the service had nothing to do with the biopsy.
• Staged treatment: Modifier 58 covers a planned next step, such as excising the mass after a positive pathology result. Modifier 78 covers an unplanned return to the operating room for a complication.
• Confirm the indicator: Global period assignments can change with an annual update. Check the current CMS relative value file before you bill any follow-up service. Assignments differ by code, so verify a neighbor like CPT 21750 separately.

A 90-day window on a diagnostic code is easy to overlook. Billing a routine wound check on day 30 as a separate visit produces a clean denial, and a repeated pattern invites a review. The same window also affects surgeons who see the patient again once pathology comes back.

Modifiers that belong on the claim

Modifiers tell payers that unusual circumstances justify a service that might otherwise be bundled or denied. The ones below are the most common on 21925 claims outside the global window. Bundling rules change quarterly, so verify current NCCI edit status before you apply any modifier.

Modifiers 57, 24, 58, 78, and 79 all relate to the 90-day global window, and the section above covers when each one applies. One modifier that does not belong on this code is -26. CPT 21925 has no professional and technical component split.

ICD-10-CM codes that support medical necessity

Medical necessity for CPT 21925 has to be supported by an appropriate ICD-10-CM diagnosis code. The diagnosis must show why a deep tissue biopsy of the back or flank was warranted. Codes are updated annually on October 1, so check the current fiscal year tabular list.

Specificity is where these claims fail. A trunk injury code such as S21.439D needs the right encounter character, and a retired code will never pay at all. Once pathology is back, bill the diagnosis the report supports rather than the pre-biopsy impression.

Billing guidelines and coding rules

Several rules govern how CPT 21925 is submitted and paid. Bundling, authorization, and medical necessity account for most of the denials and post-payment audits on this code. The global period rules sit in their own section above.

• NCCI bundling edits: The National Correct Coding Initiative defines which codes cannot be billed together without a modifier. Check the current CMS NCCI tables before billing 21925 alongside another same-day procedure. The tables are reissued quarterly.
• Biopsy taken during an excision: The biopsy generally bundles into the excision when the surgeon samples and removes the same lesion in one session. Report the excision code alone unless the biopsy addressed a separate lesion or a separate session.
• Pre-authorization: Many commercial payers require prior authorization for soft tissue biopsies. Confirm requirements with each payer before scheduling. Medicare generally does not require it for 21925, though Medicare Advantage plans set their own rules.
• Medical necessity: Documentation has to show why an open deep biopsy was needed rather than a less invasive approach. Payers may deny 21925 where a needle biopsy under CPT 20206 would have answered the same clinical question.
• No component split: 21925 is a global surgical code with no professional and technical split. In a facility, bill the full code at the facility rate rather than appending modifier 26.

Bundling, authorization, and necessity rules repeat across the musculoskeletal chapter, so a code like CPT 21720 raises the same questions. Building those rules into the submission workflow removes the manual lookup at the point of billing.

What the operative note has to say

Documentation is the first line of defense in an audit. The operative note for 21925 has to capture specific elements that justify the code billed. A note that records only soft tissue biopsy performed will not support the deep variant. Practices using digital procedure documentation can build the required fields into their note templates, so nothing is missing at submission.

Maintaining HIPAA-compliant documentation means procedure notes stay secure and stay retrievable when an audit request lands. Filing a completed surgical safety checklist with the operative note gives a reviewer the whole encounter in one place.

• Anatomical site specificity: The note must say back or flank, not trunk or posterior torso. Vague anatomical wording is a denial trigger.
• Depth confirmation: The note must state that dissection extended below the subcutaneous layer into fascia, muscle, or a deep mass. This is the single most important element for choosing 21925 over 21920.
• Biopsy versus excision: Say plainly that a specimen was taken and the lesion was left in place. This wording is what keeps the claim in the biopsy range rather than the excision range.
• Clinical indication: Record the imaging or examination finding that justified a deep biopsy, including lesion size, location, and radiological characteristics where imaging guided the plan.
• Technique description: Record the incision approach, the instruments used, the layers traversed, and how the specimen was obtained.
• Specimen handling: Document how the specimen was labeled, preserved, and submitted for analysis, then link the biopsy to the pathology report in the record.
• Pathology linkage: File the pathology report in the same encounter record. Once results arrive, the diagnosis code billed should reflect the pathological finding rather than the pre-biopsy impression.

Related CPT codes for back and flank procedures

CPT 21925 sits in a family of codes covering biopsy, excision, and radical resection of soft tissue in the back and flank. Knowing the full range helps when the surgeon removes the lesion instead of sampling it. Use the AAPC Codify CPT lookup to cross-check descriptor language before you choose.

The line between 21925 and the excision codes is straightforward. Biopsy codes apply when a sample is taken and the mass stays in situ. Excision codes apply when the lesion comes out.

The size thresholds matter too. Subcutaneous excision splits at 3 cm, while subfascial excision and radical resection both split at 5 cm. Neighboring regions follow the same pattern, and CPT 21552 covers subcutaneous excision at 3 cm or greater in the neck and anterior thorax.

Common coding errors and how to catch them

Most 21925 denials trace back to five errors, and each one leaves a signature you can search for in your own claim data. Run these checks quarterly rather than waiting for a payer to find them.

• An excision code reported after a biopsy. Look for claims carrying 21930 through 21936 where the pathology report describes a biopsy specimen. Reconcile the code against the pathology wording before submission.
• Depth missing from the note. Search your operative notes for fascia, muscle, and subcutaneous on every 21925 claim. Notes with none of those words are the ones a payer downcodes to 21920.
• 21925 treated as a minor procedure. Look for modifier 25 on E/M visits linked to a 21925 date, and for separate visits inside 90 days. Both point to the wrong global period assumption.
• An open code used for needle sampling. Flag any 21925 note that mentions core needle or percutaneous technique. Those cases belong to CPT 20206 and will not survive review.
• The wrong rate for the place of service. Pull 21925 lines billed with POS 22 or POS 24 and check them against the facility rate. Anything paid near $543 from a facility setting needs correcting.

How practice management software keeps CPT 21925 claims clean

CPT 21925 has several moving parts. Depth wording, the 090 global window, modifier choice, and ICD-10 pairing all have to agree before the claim goes out. Tracking that by hand stops working once a practice bills more than a handful of surgical codes a week.

Practice management software like Pabau keeps the procedure note and the claim in the same system. Pabau’s claims management software flags modifier requirements, checks code combinations against NCCI edits, and tracks denial patterns by CPT code. When depth is captured as a structured field in the note, it reaches the claim without a second data entry step.

The postoperative window is where a connected system pays for itself. With the biopsy date on the chart, a follow-up visit inside the 90 days is visible before anyone bills it separately. Running practice management software that holds billing and clinical notes together also keeps the link between the operative record and the claim auditable.

Knowing the descriptor is the easy part of this code. Getting paid depends on documentation capture, code validation, and modifier logic working together on the same record. Practices running notes and billing in separate systems tend to discover the mismatch at the audit instead.

Keep surgical claims clean from note to payment

Pabau’s claims management tools help practices validate CPT codes, apply the right modifiers, and track denials on surgical codes like 21925. See how it fits your billing workflow.

Book a demo

Conclusion

Two things decide whether a 21925 claim survives. The operative note has to say that dissection went below the subcutaneous layer. The 090 global period then governs the next 90 days of care, including which modifier belongs on any visit inside that window.

So the fix sits upstream of billing, not in the claim scrubber. Put a required depth field in the operative note template, and keep the biopsy date somewhere the front desk can see it. Do both and the downcode to 21920 stops happening by accident.

Pabau connects structured procedure documentation to claim submission, which removes the manual steps where errors collect. Book a demo to see how it handles surgical coding and postoperative windows in your practice.

Continue your research

Comparing claims tools before you switch billing systems? Pabau vs Waystar sets the two platforms side by side on submission, denial tracking, and reporting.

Coding dermatologic destruction procedures too? CPT 17107 walks through destruction of cutaneous vascular lesions, from descriptor to reimbursement.

Billing maxillofacial work from the same code chapter? CPT 21497 covers interdental wiring, the modifiers it takes, and how reimbursement is calculated.

Standardizing your preoperative records? History and physical form gives you a ready structure for recording patient history before a procedure.

Want tighter notes through a 90-day window? Clinical progress notes is a template for recording care as it progresses, including postoperative follow-up.

Frequently asked questions